Previous 10 | Next 10 |
NEW HAVEN, Conn., July 30, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), is announcing its COVID-19 strategy, and its intent to contribute to the battle against the ensuing worldwide pandemic. Today, the company announced it entered into an ag...
NEW HAVEN, Conn., July 22, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced its preliminary unaudited revenues for its pathology services increased from $0.8M in Q1’20, to an estimated (unaudited) $1.3M in Q2’20, an increa...
NEW HAVEN, Conn., July 01, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced that it has regained compliance with the Nasdaq listing requirements. On June 29, 2020, the Company received a letter from Nasdaq stating that because the Compa...
BioHiTech Global (NASDAQ: BHTG ) +89% on potential demand for Altapure disinfectant in COVID-19. More news on: BioHiTech Global, Inc., Kiniksa Pharmaceuticals, Ltd., CleanSpark, Inc., Stocks on the move, , Read more ...
UniQure N.V. (NASDAQ: QURE ) -16% after hemophilia gene therapy deal . More news on: uniQure N.V., KB Home, Kaleyra, Inc., Stocks on the move, , Read more ...
NEW HAVEN, Conn., June 09, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced that Cancer and Hematology Centers of Western Michigan (CHCWM) has adopted Precipio’s HemeScreen technology to launch molecular testing assay for hem...
Precipio, Inc. (PRPO) Q1 2020 Earnings Conference Call May 19, 2020, 05:00 PM ET Company Participants Miri Radomski - In-House Counsel Ilan Danieli - CEO Carl Iberger - CFO Conference Call Participants Presentation Operator Good day and welcome to the Precipio Quart...
Precipio (NASDAQ: PRPO ): Q1 GAAP EPS of -$0.78 misses by $0.59 . More news on: Precipio, Inc., Earnings news and commentary, Tech stocks news, , Read more ...
NEW HAVEN, Conn., May 15, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), filed its form 10Q for the period ending March 31 st , 2020. Within the report, the company showed a 77% net revenue increase from $0.7M in the prior quarter, to $1...
NEW HAVEN, Conn., May 12, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its Quarter1-2020 corporate update call on Tuesday, May 19 th at 5:00 PM ET. The conference call may be accessed by calling 844-695-5519 ...
News, Short Squeeze, Breakout and More Instantly...
NEW HAVEN, Conn., July 25, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that its unaudited non-GAAP Cash Burn/Generated from Operations (CBFO) for Q2-2024 was $0.3M of cash generated for the quarter. It is important to not...
NEW HAVEN, Conn., July 17, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that for Q2-2024, its unaudited revenues have grown from $3.4M in Q1-2024 to $4.4M in Q2-2024, an increase of 30% from one quarter ago. Patholog...
NEW HAVEN, Conn., June 13, 2024 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) , today announced that the company’s 2024 Annual Meeting of Shareholders (“Annual Meeting”) was convened and adjourned, without any business being conducted...